{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:34:30Z","timestamp":1761964470707},"reference-count":17,"publisher":"Japan Society for Clinical Immunology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. J. Clin. Immunol.","Jpn.J.clin.Immun"],"published-print":{"date-parts":[[2013]]},"DOI":"10.2177\/jsci.36.71","type":"journal-article","created":{"date-parts":[[2013,4,27]],"date-time":"2013-04-27T23:01:11Z","timestamp":1367103671000},"page":"71-76","source":"Crossref","is-referenced-by-count":37,"title":["Anti-MDA5 (melanoma differentiation-associated gene 5) antibody and dermatomyositis with rapidly progressive interstitial pneumonia"],"prefix":"10.2177","volume":"36","author":[{"given":"Ran","family":"NAKASHIMA","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Kyoto University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuneyo","family":"MIMORI","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","unstructured":"1) Sato S, Hirakata M, Kuwana M, et al. : Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. <i>Arthritis Rheum<\/i>. <b>52<\/b> : 1571-1576, 2005."},{"key":"2","unstructured":"2) Sato S, Hoshino K, Satoh T, et al. : RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis : Association with rapidly progressive interstitial lung disease. <i>Arthritis Rheum<\/i>. <b>60<\/b> : 2193-2200, 2009."},{"key":"3","unstructured":"3) Nakashima R, Imura Y, Kobayashi S, et al. : The RIG-I-like receptor IFIH1\/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. <i>Rheumatology (Oxford)<\/i>. <b>49<\/b> : 433-440, 2010."},{"key":"4","unstructured":"4) Kato H, Takeuchi O, Sato S, et al. : Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. <i>Nature<\/i>. <b>441<\/b> : 101-105, 2006."},{"key":"5","unstructured":"5) Nawata Y, Kurasawa K, Takabayashi K, et al. : Corticosteroid resistant interstitial pneumonitis in dermatomyositis\/polymyositis : prediction and treatment with cyclosporine. <i>J Rheumatol<\/i>. <b>26<\/b> : 1527-1533, 1999."},{"key":"6","unstructured":"6) Christensen ML, Pachman LM, Schneiderman R, et al. : Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis. <i>Arthritis Rheum<\/i>. <b>29<\/b> : 1365-1370, 1986."},{"key":"7","unstructured":"7) Gono T, Kawaguchi Y, Satoh T, et al. : Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. <i>Rheumatology (Oxfor).<\/i> <b>49<\/b> : 1713-1719, 2010."},{"key":"8","unstructured":"8) Hoshino K, Muro Y, Sugiura K, et al. : Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis. <i>Rheumatology (Oxford).<\/i> <b>49<\/b> : 1726-1733, 2010."},{"key":"9","unstructured":"9) Fiorentino D, Chung L, Zwerner J, et al. : The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-14) : a retrospective study. <i>J Am Acad Dermatol<\/i>. <b>65<\/b> : 25-34, 2011."},{"key":"10","unstructured":"10) Gono T, Kawaguchi Y, Ozeki E, et al. : Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis. <i>Mod Rheumatol<\/i>. <b>21<\/b> : 223-237, 2011."},{"key":"11","unstructured":"11) Tanizawa K, Handa T, Nakashima R, et al. : HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody. <i>Respir Med<\/i>. <b>105<\/b> : 1380-1387, 2011."},{"key":"12","unstructured":"12) Gono T, Sato S, Kawaguchi Y, et al. : Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. <i>Rheumatology (Oxford)<\/i>. <b>51<\/b> : 1563-1570, 2012."},{"key":"13","unstructured":"13) Gono T, Miyake K, Kawaguchi Y, et al. : Hyperferritinaemia and macrophage activation in a patient with interstitial lung disease with clinically amyopathic DM. <i>Rheumatology (Oxford).<\/i> <b>51<\/b> : 1336-1338, 2012."},{"key":"14","unstructured":"14) Nagasaka K, Masayoshi H, Matsuto T. : Efficacy of combination treatment with cyclosporin A and corticosteroids for acute interstitial pneumonitits associated with dermatomyositis. <i>Modern Rheumatology<\/i>. <b>13<\/b> : 231-238, 2003."},{"key":"15","unstructured":"15) Kotani T, Takeuchi T, Makino S, et al. : Combination with corticosteroids and cyclosporin-A improves pulmonary function test results and chest HRCT findings in dermatomyositis patients with acute\/subacute interstitial pneumonia. <i>Clin Rheumatol<\/i>. <b>30<\/b> : 1021-1028, 2011."},{"key":"16","unstructured":"16) Ozawa Y, Kurosaka D, Yokoyama T, Tajima N. : [Therapeutic efficacy of cyclosporin A in four cases of amyopathic dermatomyositis with rapidly progressive interstitial pneumonia]. <i>Ryumachi<\/i>. <b>40<\/b> : 798-809, 2000."},{"key":"17","unstructured":"17) Kameda H, Nagasawa H, Ogawa H, et al. : Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute\/subacute interstitial pneumonia in patients with dermatomyositis. <i>J Rheumatol<\/i>. <b>32<\/b> : 1719-1726, 2005."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/36\/2\/36_71\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T04:54:35Z","timestamp":1621486475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/36\/2\/36_71\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.36.71","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}